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INTRODUCTION 
Over the past decade the mortality from myocardial 
infarctions has been reduced significantly by the close 
monitoring and rapid treatment of its arrhythmic complications. 
With the development of new medical and surgical techniques 
designed to salvage ischemic myocardium, the knowledge of the 
site and size of a myocardial infarction has assumed greater 
therapeutic importance. This last point is most significant 
since the location, extent, and degree of associated ventric¬ 
ular dysfunction are major determinants governing the hemody¬ 
namic consequences and thus, the clinical course of a myocar¬ 
dial infarction. 
Serum creatine phosphokinase enzyme determinations 
(1-3) and precordial ST segment mapping (4-6) are two rela¬ 
tively new, non-invasive methods for assessing the degree of 
myocardial damage. In addition, they have been used to gauge 
the effectiveness of certain drug and mechanical interven¬ 
tions designed to limit the amount of myocardial necrosis. 
It is well recognized, however, that precise electrocardio¬ 
graphic documentation of myocardial infarction is difficult 
if not impossible in some situations of previous myocardial 
infarction, of subendocardial infarction, and of left bundle 
branch block or other conduction delay. In addition, the 
specificity of cardiac enzyme abnormalities can be compromised 
by concomitant congestive heart failure, hemolysis, brain or 

pulmonary damage, or Intramuscular injections. Presently, 
the technique of radionuclide myocardial imaging holds 
promise as an alternative means of accurate qualitative and 
quantitative evaluation of ischemic and infarcted myocardium. 
Non-invasive radionuclide imaging can visualize the 
region of ischemia and/or infarction in two general ways. 
On the one hand, radioisotopes of an intracellular cation 
such as potassium (K) or its analogues. Rubidium (Rb) 
Cesium (Cs), and Thallium (Tl), accumulate maximally in 
normal myocardium and minimally in ischemic tissue (7-1*0 . 
Myocardial imaging of such a distribution would reveal the 
zone of infarction or ischemia as an area of relatively 
decreased radioactive tracer accumulation or "cold spot." 
Qualitatively, it cannot differentiate new from old areas 
of infarction but can be used to define transiently ischemic 
tissue. 
Alternatively, other radionuclides such as tech- 
netium-99m labeled stannous pyrophosphate, tetracyline, or 
glucoheptonate and radioactively labelled myosin specific 
antibody, have a strong affinity for and maximally concen¬ 
trate in recently infarcted myocardium (15-24). Imaging 
reveals the region of infarction as a zone of increased 
radionuclide accumulation or "hot spot." Although hot spot 
tracers are specific for recent infarctions, it is unclear 
whether they accumulate solely in necrotic cells or in 
reversibly damaged tissue as well. 
By using both types of scanning agents simultaneously 
in the acute infarction period, one may be able to define 
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precisely the region of infarction and more importantly, 
an area of periinfarction ischemia. In fact, several 
recent reports suggest that the information obtained by 
scans with both types of agents is complementary and improves 
their overall accuracy (15, 25, 26). Furthermore, initial 
trials with both types of imaging agents have been used 
successfully to quantify the amount of abnormal ventricular 
myocardium present. Thus, serial evaluations of a myocardial 
infarction by dual radionuclide imaging may be useful for 
the assessment of therapeutic interventions during the course 
of a myocardial infarction. 
Before it is appropriate to utilize this approach 
to quantify gradations of abnormality within the infarcted 
left ventricle, it is necessary to define accurately the 
pathophysiologic correlates of myocardial radionuclide 
uptake. With this purpose the myocardial distributions of 
41 
potassium-43 ( K) and technetium-99m stannous pyrophosphate 
Tc-PYP) were studied simultaneously in a canine model 
of acute myocardial infarction. Their interrelationships 
were evaluated and their regional uptake compared to regional 
myocardial blood flow, as measured by the radioactive micro¬ 
sphere technique. A review of the theoretical and experimental 
characteristics of microsphere estimates of regional myocardial 
4 3 99m 
blood flow and of the dual radionuclides K and Tc-PYP 
will be followed by a presentation of the experimental data 
and a discussion of the implications of this study. 
- 3 - 

MICROSPHERE DETERMINATIONS OP REGIONAL MYOCARDIAL BLOOD FLOW 
Blood flow to the whole heart or to specific regions 
of it is a desirable and valuable measurement for both research 
and clinical evaluations (27). It would allow one to assess 
and define the physiological basis for critical coronary sten¬ 
osis in experimental animals and in the clinical evaluation of 
patients with coronary artery disease (28). In addition, it 
would enable one to assess collateral blood flow and therapeu¬ 
tic manipulations of coronary blood flow (29-31). Finally, one 
could use it as a reference standard in the experimental eval¬ 
uation of indirect and/or non-invasive methods of determining 
regional myocardial perfusion (32). 
The determination of coronary blood flow, however, 
is difficult to measure experimentally. Electromagnetic or 
ultrasonic flowmeters or indicator dilution techniques are 
applicable for total flow but are difficult to perform for 
technical reasons. In addition, none of these can measure 
flow to a-ventricle or any specific portion of it. Other 
methods, nitrous oxide washout (33)s washout of indicators 
injected into the myocardium (3*0 or the coronary arteries (35), 
and isotope clearance techniques (36), either measure flow 
per unit weight of myocardium without referring to a specific 
region of the heart or are technically unsatisfactory because 
of the necessity of intracoronary injections. 
In 1967 Rudolph and Heymann reported a method of 
measuring cardiac output to various organs by injecting 
carbonized microspheres labeled with gamma emitting nuclides 
(37). In principle, if the microspheres are well mixed prior 
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to ejection, are distributed according to blood flow, do not 
escape from the organs and do not disturb the circulation, 
then their fractional distribution will be proportional to 
the fraction of cardiac output going to those organs. Thus, 
if the flow to any organ is known, flow to another organ can 
be determined. In addition, since the microspheres are 
trapped in the precapillary vessels in their first transit, 
the radioactivity of any region within an organ is proportional 
to blood flow to that region. 
Domenech et al. and Fortuin et al. proved that these 
assumptions held for the heart and that one could determine 
coronary blood flow (38, 39). More importantly, however, both 
groups showed that one could assess regional myocardial blood 
flow with microspheres. For example, using several different 
size microspheres they found that the left ventricle received 
approximately one and one half times the flow of the right 
ventricle, presumably because the increased energy require¬ 
ments of the left ventricle necessitates higher blood flow. 
Similarly, they reported that the endocardial half of the ven¬ 
tricular wall receives more flow than the epicardial half. 
This measurement, however, varied with the size of the micro¬ 
sphere used, and one of the limitations of the microsphere tech¬ 
nique became obvious. With large microspheres (50 microns) 
the endocardial to epicardial radioactivity ratio was 1.45 
versus 1.12 for 15 micron microspheres. Other techniques 
reported values slightly above 1 (40,4l). The falsely high 
value with large microspheres can be accounted for in two ways. 
- 5- 

The large spheres would tend to stay in the center of blood 
flow and follow the perforating vessels to the endocardium. 
On the other hand, the smaller 15 micron spheres travel more 
peripherally like a red blood cell, have less tendency toward 
axial streaming, and distribute more easily to the epicardium. 
In addition, the 50 micron spheres may become trapped in the 
subendocardial plexus which fills with blood during diastole 
and then empties during systole because of high intramyocardial 
tension. Thus, the 15 micron spheres would more accurately 
estimate actual myocardial blood flow while the larger micro¬ 
spheres reflect flow during diastole alone. Smaller spheres 
also have several other advantages over larger ones. They 
are distributed more like red blood cells, occlude less of 
the vascular bed, are less variable in size, and most impor¬ 
tantly can be given safely in greater amounts, thus allowing 
more reliable measurements of flow to small regions. 
Buckberg et al. not only confirmed the validity of 
using microsphere techniques for measuring coronary blood 
flow, but also evaluated the sources of error inherent in 
this technique (42). Their results showed that differences 
in blood flow determinations are generally the result of 
random variation, i.e. poor mixing of the microspheres. These 
errors, however, could be minimized as long as each sample 
contained at least 400 microspheres. Furthermore, while 
smaller numbers of microspheres will be associated with larger 
random errors and a low precision of estimate, they would not 
systematically over-or underestimate mean flow. More 
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experiments, however, would be needed to demonstrate the 
significance of any given difference. Thus, the greatest 
precision occurs with the injection of the largest number 
of microspheres consistent with no physiological changes. 
Fortuin et al. showed that the reactivity of the coronary 
vascular bed, manifested by the ability to increase flow 
after a hyperemic stimulus such as transient coronary occlu- 
£ 
sion, was not diminished significantly by as many as 12x10 
15 micron microspheres (39). 
Having observed these caveats, other experimenters 
reported important findings about regional myocardial blood 
flow that were especially pertinent to the endocardium since 
its blood flow is almost entirely diastolic, and thus more 
prone to ischemia (43). In dogs with normal coronary arteries 
Fortuin et al. showed endocardial blood flow was increased by 
propranolol, decreased by isoproterenol, and unchanged by 
nitroglycerin (39). In dogs with acute occlusions, Domenech 
found a radial gradient of flow with increasing flow from 
the center of the infarct outward (44). In a similar experi¬ 
ment, Becker et al. reported not only the same radial gradient 
of flow, but also that there was an inordinate reduction of 
flow to the endocardial half of the left ventricular wall (45) 
Other reports by Moir (46) and by Becker et al.(30) demonstra¬ 
ted that one could alter this disproportionate endocardial 
flow reduction in the ischemic area with nitroglycerin or 
propranolol. 
Recent experiments using epicardial electrode maps 
and microsphere estimates of blood flow (31), showed that 
7 

while the beta adrenergic blocker, propranolol, decreased 
blood flow to the ischemic area, ST segment elevation also 
decreased. Similarly, isoproterenol increased blood flow and 
ST segment elevation. While they conclude that beta adren¬ 
ergic agents do not alter ischemia through primary changes 
in blood flow distribution, it is well known that epicardial 
electrodes are insensitive to endocardial events. 
Other experimenters have used microsphere estimates 
of blood flow to evaluate the perfusion estimates obtained 
with radioactive nuclides. Prokop et al. compared potassium-43 
to labeled microspheres in terms of their ability to reflect 
alterations in regional myocardial blood flow (32). They 
found excellent correlation under conditions of normal and 
4 P decreased flow although JK was slightly less reduced at 
very low flows. Endocardial to epicardial flow ratios also 
4 3 
agreed very well. At higher than normal flows, however, K 
estimate did not increase to the same extent as microspheres 
flow determinations. In similar experiments Becker et al. and 
Strauss et al. respectively compared Rubidium-86 and Thallium-201 
estimates of regional myocardial perfusion to that obtained 
with microspheres (47,48). They also demonstrated excellent 
correlation except at very reduced flows or in cases of 
reactive hyperemia. 
In conclusion, microspheres are accurate indicators 
of regional myocardial blood flow. They thus can be used as 
a reference standard to evaluate drug as well as other manipu¬ 
lations of coronary blood flow, and to evaluate the relation- 
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ship of flow to the myocardial uptake of other materials or 
to other parameters of cardiac function such as ST segment 
mapping. 
POTASSIUM-43 
Potassium, one of the key intracellular cations, 
plays an important role in cellular metabolism. Cellular 
efflux of potassium, as evidenced by increased potassium ion 
in coronary sinus blood after atrial pacing, can be indica¬ 
tive of myocardial cell ischemia (49). Thus, differences in 
both intra- and extracellular potassium concentrations can 
reflect pathologic changes in the myocardium. Studies of 
potassium kinetics in the normal and diseased heart, therefore, 
were undertaken first with potassium-42 and then with potas¬ 
sium-43 in the hope that these radioactive isotopes could be 
useful in identifying ischemic myocardium. 
Myocardial accumulation of radioactive potassium 
42 
was first reported in 1941 with K (50). This work was not 
pursued, however, until 1954 when Love et al. reported similar 
86 42 
myocardial uptake of both Rb and K (51). Accumulation in 
the myocardium was secondary to both regional myocardial blood 
flow and cellular uptake of the radioactive cation. In 1955 
Conn and Robertson studied the kinetics of this transfer in 
the canine left ventricle (52), and by 1958 Sapirstein had 
shown that one could calculate myocardial blood flow by using 
the fractional uptake of potassium-42 by that organ (53). 
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An important development came in 1964, however, when 
Donato et al. showed that one could accurately quantitate the 
42 86 
myocardial clearance of K and Rb by precordial counting 
after intravenous injection of the tracers (54). Their cal¬ 
culation of myocardial clearance of potassium agreed with 
estimates of myocardial blood flow obtained by the indirect 
Fick method and furthermore, showed that every unit of myo¬ 
cardium contributes to precordial counting rate. Thus, they 
showed that external counting of radionuclides could be cor¬ 
related to myocardial perfusion. 
42 
Trials with K as a cold spot indicator of reduced 
coronary perfusion were also attempted. In animals with 
experimentally induced coronary stenosis Love et al. located 
42 
the area of reduced perfusion with K scans (55). Bennett 
et al. showed that there was good correlation between poorly 
42 perfused areas on K scans and stenosis of coronary arteries 
supplying these areas (56). During this same period other 
investigators were also experimenting with analogues of potas¬ 
sium such as cesium and rubidium, as ’’cold spot" indicators 
of infarction, and there were several reports of successful 
detection of myocardial infarction (57, 58). These isotopes 
of rubidium (^Rb) and Cesium ( ^31cs ) have not been completely 
satisfactory, however, because their gamma ray and other 
emissons have not been suitable for detection by conventional 
42 imaging instruments in doses permissible in man. K also 
emits a high energy proton which makes detection and imaging 
of the myocardium difficult. 
43 
In 1971, however, a new radioisotope of potassium, K, 
- 10 
V 
was reported by Hurley et al. to be useful in imaging acute 
myocardial infarction, and many of the advances in cold spot 
imaging in the clinical setting have been done using this 
isotope (59). They showed that K localized predominantly 
in the left ventricular and septal muscle. As with other 
isotopes mentioned, the thinner right ventricle and atria 
were less well defined and areas of infarction were seen as 
43 
"cold spots.” In clinical trials with K, 19 of 20 patients 
with myocardial infarction had excellent correlation of 
electrocardiographic, enzyme, arteriographic, and ventriculo- 
graphic data with abnormalities on perfusion scan (60). 
il o 
Zaret and others extended the use of JK perfusion 
scans to the study of ischemic as well as infarcted myocardium 
by evaluating patients both at rest and during maximal tread¬ 
mill exercise (7). In the resting state, non-infarcted myo¬ 
cardium supplied by stenotic major coronary arteries are 
probably adequately perfused either through the stenotic 
vessel itself or through collaterals. With exercise, however, 
these areas are subject to inadequate perfusion. In 12 
43 
normal subjects K distribution was homogenous both at rest 
and during exercise. In 13 of 15 patients with previous myo¬ 
cardial Infarction studied at rest, regions of decreased 
radionuclide accumulation corresponded to the anatomic 
location of the Infarct. In 16 of 19 patients with angina 
43 
pectoris clinically, regions of decreased K accumulation 
were present when the tracer was given during exercise but 
not at rest. Furthermore, these zones of relative hypoper¬ 
fusion corresponded to regions supplied by angiographically 
11 

proven stenotic coronary arteries. 
JK scans also were used to study false positive 
electrocardiogranhic exercise tests. These patients had 
normal coronary arteriography, left ventriculography and hemo¬ 
dynamic evaluation. All nine patients who were exercised to 
43 
the point of abnormal ECG changes and then given K intra¬ 
venously showed a homogenous distribution of isotope. This 
is in contrast to patients with coronary artery disease who 
4 "5 
show abnormal regions on -’K scan during exercise-induced 
ischemia (61). 
Patients undergoing surgery for myocardial revascular¬ 
ization, also were studied both pre-and post-operatively and 
4 3 
showed definite improvement in perfusion with the K scan 6 
to 14 days after surgery (62). Zaret et al. demonstrated the 
value of the scan in assessing tne results of coronary 
bypass surgery (63). Scans which showed improved or normal 
uptake correlated well with 13 of 16 patent grafts seen on 
postoperative angiography. Scans which had not improved or 
worsened correlated with patients who had experienced intra¬ 
operative infarction, those with significant distal coronary 
artery disease, and those with occluded grafts. Finally, 
43 
computer analysis of serial K scans in patients undergoing 
revascularization surgery demonstrated higher uptake after 
surgery (64). 
43 
Finally, Zaret et al. used K to semi-quantify 
myocardial infarctions (9). In 15 consecutive post MI 
patients who underwent angiographic evaluations, the total 
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area of K hypoperfusion on myocardial scanning correlated 
very highly with the total area of abnormally contracting 
43 
segments of the left ventricle by angiography. Thus, K 
is useful for not only qualitative evaluation of the myocar¬ 
dium but also for quantification of the amount of abnormal 
tissue present in the left ventricle. 
43 
The diagnostic accuracy of K scans was compared 
to clinical, laboratory, electrocardiographic, and catheter¬ 
ization data in 85 patients (65). While two cardiologists 
interpreted all information except the scan, nuclear 
medicine specialists interpreted only the scan. The signif¬ 
icantly high agreement between the two modes of investigation 
was as follows: in previous myocardial infarction 88% agree¬ 
ment ; in acute infarction 94%; in patients with coronary 
artery disease but without infarction 89% agreement. Thus, 
43 JK is useful in the qualitative and quantitative evaluation 
of myocardial ischemia. 
The physical characteristics of potassium-43, however, 
do present drawbacks for routine clinical use (66,67). Since 
it is produced from a cyclotron and has a very short half life, 
its costs and availability limit widespread applicability. 
Furthermore, while the total body dose of radiation is very 
low (0.81 rads per millicurie), its high emission energies 
43 (peaks of 590-610 and 370-390 KeV) make imaging difficult. K 
was used in this study, however, not only because of this 
laboratory’s extensive use and familiarity with this tracer, 
but also because the mechanism in which the myocardium handles 
"cold spot" monovalent cations is generally similar. Thus, 
-13 

43 
statements about the uptake of K and its relationship to 
the distribution of hot spot agents would generally hold for 
newer agents such as Thallium-201 and Rubidium-81. 
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TECHNETIUM-99m STANNOUS PYROPHOSPHATE 
The use of a positive infarct-imaging agent was 
first reported in 1962 by Carr et al. who described the use 
203 
of Hg-Chlormerodrin for photoscanning experimental myo¬ 
cardial infarctions in dogs (68). Since 1970 work in this 
area has increased exponentially and many radiopharmaceu¬ 
ticals which are sequestered by acutely infarcted tissue 
203 
have been developed. Amont these are the mecurials, Hg- 
Chlormerodrin (68) and Hg-Mercurifluorescein (69), gallium- 
67 citrate (70), and technetium-99m-labelled tetracycline 
(18), glucoheptonate (19-22), and pyrophosphate (15-17), and 
radioactively labeled myosin specific antibody (23-24). 
The early work done with these compounds pointed 
out not only their shortcomings but also some of the ideal 
qualities necessary for a positive scanning agent. Although 
initial trials with a number of different mercurial compounds 
were promising in animal infarctions, attempts to extend 
this work to man were uniformly unsuccessful (68,69). The 
major cause for failure may have been the low radioactivity 
ratios between normal and diseased tissue which prevented 
good resolution infarct scanning, although inadequate amount 
of tracer and other technical difficulties were contributory. 
In addition, the high dose of radiation to the kidneys and 
long half life of Hg (45 days) were distinct drawbacks 
for human use. 
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In 1973 Kramer et al. reported that gallium-67 
citrate, a radiopharmaceutical which accumulates in inflam¬ 
matory and neoplastic tissue, also concentrates significantly 
in regions of experimental canine infarction (70). Concen¬ 
trations in adjacent structures, however, caused great dif¬ 
ficulty in interpretation of the gallium myocardial scan and 
have limited its applicability. 
Similarly, Malek et al. demonstrated in 1963 that 
tetracycline accumulated around an area of myocardial infarc¬ 
tion (71). By combining the excellent physical characteristics 
9 9m 9 9jn 
of Tc with tetracycline and applying Tc-tetracycline to 
the myocardium, Holman et al. not only demonstrated that "hot 
spot" infarct scanning could detect and size an acute myocar¬ 
dial infarction but also made a major advance toward developing 
the ideal hot spot agent (18). Tc-tetracycline does have 
drawbacks however. First of all, it labels the liver so that 
diaphragmatic or inferior myocardial infarctions are difficult 
to visualize. Further, one must wait twenty-four hours after 
infarction before intravenous technetium-99m tetracycline will 
begin to accumulate in infarcted tissue; then one must wait 
an additional twenty-four hours before it is adequately con¬ 
centrated to give meaningful images. 
The bone scanning agent technetium-99m pyrophosphate 
(99mTc_pYp) has overcome these problems of safety, inadequate 
or slow uptake, and interference from surrounding tissue 
accumulation and has proven to be the most successful agent 
for myocardial scintograms yet developed. A recent comparative 
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Q Q]j| 
study. In fact, showed the superiority of ' Tc-PYP over 
technetium-99m labeled tetracycline and glucoheptonate in 
detecting myocardial Infarction (22). 
99m 
Bonte et al. first demonstrated that Tc-PYP 
scintograms are positive in dogs with experimental myocardial 
infarction (16). These abnormal scintograms begin as early 
as twelve hours after infarction and from 45-60 minutes 
after intravenous injection of the isotope and remain unchanged 
for approximately six days. Thereafter they begin to fade, 
ordinarily becoming negative by the 14th post-infarction day. 
Similarly, in 202 patients admitted with chest pain of uncer¬ 
tain etiology, Willerson et al. demonstrated that there was 
almost precise correlation between the ECG and ^mTc-PYP 
localization of the site of acute transmural infarctions (17). 
The time course of positive scintograms was similar to that 
shown in dogs. Of the 101 patients with clinical and labor¬ 
atory confirmed myocardial Infarction only five had negative 
scans and these were all performed seven or more days after 
infarction. Furthermore, because of its short half life, 
repeat ^mTc-PYP scans could be obtained at 24 hour intervals 
for sequential evaluation. Of the 101 patients without 
confirmed infarction only nine had a positive scan and sig¬ 
nificantly, seven of these had a clinical diagnosis of 
"unstable angina pectoris." Klein et al. also showed that 
99mTC-PYP scans were highly sensitive indicators of infarction 
when compared to creatine phosphokinase (CPK) Isoenzyme 
determinations (72). In addition they stated that isoenzymes 
9 9m 
and Tc-PYP scintigrams are concordant after graded ischemia 
17 

in dogs . 
Furthermore, the difficult diagnosis of subendocardial 
Q Q]JJ 
myocardial infarction could be made with " Tc-PYP scintograms 
(73). Recent reports, however, do suggest that the accuracy 
of Tc-PYP scans can be improved by concomitant imaging 
with a cold spot agent especially in cases of subendocardial 
infarctions (25, 26). 
Q Qttj 
Although the ability of Tc-PYP to define precisely 
an area of myocardial infarction or ischemia has been clearly 
demonstrated, information regarding its ability to quantitate 
the size of infarction remains incomplete. In preliminary 
studies by Shames et al. (7*0, Willerson et al. (75), and 
Botvinick et al. (76), there was excellent correlation between 
size of infarction as determined by scintograms and by path¬ 
ologic analysis. In humans, Willerson et al. showed good 
99m 
correlation between total serum CPK and Tc-PYP myocardial 
scintogram determinations of infarct size in anterior but 
not in Inferior or subendocardial myocardial Infarctions. 
Further work is In progress and centers around the use of 
both a hot spot and a cold spot indicator of Infarction to 
better define the area of damage. Initial reports by Poe 
et al. using Cesium-129 and ^mTc-PYP and either or ^^Tl 
showed that valuable additional information was gained about 
the site and size of infarction (15,25,26). 
Quantification with ^^mTc-PYP, however, will also 
depend on better understanding of the difficult and contro¬ 
versial questions regarding its mechanism of cellular uptake 
- 18 

9 9m 
and localization. In bone scanning ' Tc-PYP, an anionic 
chelator, is most likely bound to the bone cations, chiefly 
calcium. In 1964 D'Agostino noted that calcium localized 
in the mitochondria of myocardial cells in steroid-induced 
focal necrosis (78). Furthermore, he and Chiga noted that 
it seemed to be bound in a crystalline structure which they 
believed to be hydroxyapatite (79). Finally, Shen and 
Jennings described similar calcium accumulation as an 
index of irreversible ischemic myocardial cell damage (89). 
These observations thus led Bonte et al. to their Initial 
animal infarction experiments mentioned above. 
Further morphologic work on this problem by Buj a 
Q Qjy} 
et al. has been Interpreted as supporting the idea of Tc-PYP 
as a hydroxapatite labeling agent (8l,82). In some dogs 
with experimental myocardial infarction, positive myocardial 
scintograms showed a "doughnut'’ pattern, characterized by 
marked peripheral concentration of radioactivity around 
central zones of much lower activity and this was confirmed 
by relative tissue radioactivity counts. When these tissues 
were examined histologically, there was selective occurrence 
In the peripheral zones of calcified muscle cells with ultra- 
structurally demonstrable apatite-like crystals in the mito¬ 
chondria. Buja et al. Interpreted this as presumptive 
evidence favoring a temporal and topographical relationship 
o Qin 
between calcium accumulation and Tc-PYP uptake in acute 
myocardial infarcts. They also admitted, however, that 
Q Gift 
Tc-PYP uptake may have resulted from accumulation in 
regions of residual perfusion into which the agent could 
-19 - 

gain access. This point is bolstered by the reports of 
Q 
Poe et al. who showed that high Tc-PYP were often found 
4 3 
with good K concentrations and concluded that some per¬ 
fusion is necessary for positive ^mTc-PYP uptake (82). 
Furthermore, other localization studies notably by Dewanjee 
et al. seem to indicate that apatite formation is not 
Q Q-m 
directly responsible for localization of ^ Tc chelate 
(84). By differential centrifugation studies Dewanjee 
et al. showed that 50% of the radioactivity is in the lyso- 
zomal enzyme fraction of the cell while only 10-20% is in 
the mitochondrial fraction. The mitochondria, however, are 
the subcellular site of calcium localization following infarc- 
Q Qrn 
tion. Thus, the biochemical mechanisms governing Tc-PYP 
uptake have not been resolved. 
99m 
At the present time, then, Tc-PYP has been shown 
to be a safe (85) and sensitive method of detecting myocardial 
infarcts as early as 12 hours after their development. It 
has also 'proven useful in quantifying the extent of myocardial 
99m 
damage. While newer agents such as Tc-glucoheptonate and 
radioactively labeled myosin specific antibody accumulate 
earlier in the course of a myocardial infarction, much 
experimental work must be done before any hot spot substance 
will be proven as efficacious as ^mTc-PYP (22-24). 
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MATERIALS AND METHODS 
I RADIONUCLIDES 
The microspheres used in this study were supplied 
by the Nuclear Products Division of Minnesota Mining and 
Manufacturing Company. They had an average diameter of 
15+5 microns and were labeled with Chromium-51s an iso¬ 
tope with principle peak gamma radiation of 320 KeV and a 
half life of 27.8 days. They were suspended in 10% dextran, 
had a specific activity of 10.8 millicuries (mCi) per gram, 
and a concentration of 4.4 x 10^ spheres per milliliter (ml). 
Potassium-43 was obtained as a cyclotron-produced, 
sterile, pyrogen-free radionuclide in 0.9% normal saline 
from Oak Ridge National Laboratories, Oak Ridge, Tennessee. 
Its composition at calibration time was ^K-lmCi/ml+O.2 
4 ? 
mCi/ml and it contained less than 5% K. Its peak energies 
are at 590-610 and 370-390 KeV and it has a 22.4 hour physical 
half-life. 
The technetium-99m stannous pyrophosphate was 
obtained commercially from Mallinckrodt Chemical Works. 
Technetium-99m has a peak energy of 140 KeV and a physical 
half-life of 6.8 hours. 
II ANIMAL PROTOCOL 
Adult mongrel dogs of either sex weighing between 
20 and 35 Kg were used for all studies. A closed-chest 
myocardial infarction was created by modification of the 
catheter plug embolization technique of Cohen and Eldh as 
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follows (86). Animals were lightly anesthetized with intra¬ 
venous sodium pentobarbital (30 mg/kg) and then intubated. 
The neck and anterior and lateral thorax were shaved. After 
a right jugular venous cutdown for fluid and medication 
administration was performed, a number 7 Sones catheter was 
introduced into'the aortic root via the right carotid artery. 
After subselective positioning of the catheter into the left 
anterior descending coronary artery under fluoroscopic control, 
a guidewire-impaled plug present at the catheter tip was 
dislodged into the coronary circulation. This plug was 2-^mm 
long and made from the solid tip of a polyethylene angiographic 
catheter; it would generally lodge in the distal one third 
of the coronary circulation at the origin of the last large 
diagonal branch of the anterior descending. Animals were 
placed on a Harvard respirator and were pretreated with a 
lOOmg-bolus of xylocaine just prior to infarction. A xylocaine 
infusion of 2 mg./min. was maintained for 90 minutes post¬ 
infarction. EKG monitoring was maintained throughout the 
experiment. Short bursts of ventricular ectopy were common 
following embolization and were treated with 50 to 100 mg. 
boluses of xylocaine. Precordial ST segment elevation was 
noted in all animals. When the animals appeared electrically 
stable, the cutdown was closed, 100 mg of xylocaine infiltrated 
subcutaneously around the wound, 200 mg of xylocaine admin¬ 
istered intramuscularly and they were allowed to recover in 
their cages. Overall mortality secondary to ventricular 
arrhythmias was 20%. 
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Twenty—four hours following infarction the conscious 
99m 
animal received 10 mCi of Tc-PYP intravenously. An hour 
43 
later 0.5 mCi of K was also given intravenously. One 
minute after the K injection, the dogs were anesthetized, 
endotracheal intubation performed, and respiration maintained 
on a Harvard respirator. A lateral thoracotomy was performed 
at the level of the left fourth intercostal space to obtain 
adequate exposure of the beating heart. The left atrial appen¬ 
dage was then cannulated and approximately 4.4-6 million 
15+5 micron diameter microspheres were administered. The 
microspheres had been under constant agitation in an ultra¬ 
sonic bath for at least 15 minutes before injection and also 
had been vigorously shaken manually; these two procedures 
retard settling and clumping of the microspheres. This large 
number of microspheres was employed to improve overall counting 
statistics and has been shown not to alter coronary blood flow 
significantly (39). 
Two minutes following microsphere injection the 
heart was removed and washed. In all instances the site of 
plug embolization could be identified and epicardial demarc¬ 
ation of the site of infarction was evident. The atria, 
right ventricle, and interventricular septum were dissected 
free from the left ventricle. Samples were obtained from the 
mid-left anterior descending distribution of the left ven¬ 
tricle (infarct zone) and from the normal circumflex distribu¬ 
tion of the lateral wall. Approximately 12-16 two gram myo¬ 
cardial samples were obtained from each animal. The topography 
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of each sample in relation to the infarct zone and coronary 
anatomy was recorded. Samples were trimmed of epicardial 
fat and blood vessels and divided into approximately equal 
one gram endocardial and epicardial halves. 
Samples then were counted in a well-type scintilla¬ 
tion counter. Utilizing differential spectrometry 43 K 
51, 
activity was counted at a window from 560-660 KeV, J Cr 
Q Q]']’} 
microsphere activity at a window of 300-340 KeV and Tc-PYP 
at a window of 100-140 KeV. After physical decay of a major 
43 portion of the overlapping higher energy K, a more optimal 
51 51 43 
condition existed for counting Cr. Therefore, Cr and K 
activity was recounted approximately four days after study. 
43 4c 51 
By counting a K standard in the K, Cr, and 
•^mTc windoxvs and a "^Cr standard in the ^Cr and ^mTc windows, 
4 3 
ratios were obtained for correcting the higher activity K 
51 Q 9m 4 *3 
and Cr in the Tc window and for correcting the K 
51 51 
activity present in the Cr window. For example, Cr 
counts per minute (cpm) is equal to the raw counts in the 
51 Cr window minus the counts there due to scatter from the 
43 higher energy K. This number is obtained by multiplying 
43 43 the K ratio times the raw counts in the JK window. Thus, 
the calculations are represented by using the following 
abbreviations: 
Ok STD in ^K window = A 
Ok STD in 51 Cr window = B 
Ok STD in •^mTc window = C 
5^Cr STD in ^Cr window = D 
- 24 - 

5hr ’ STD in ^mTc window=E 
Raw Counts in 
in 42 
wmdow= 
Raw Counts in ■^Cr windov/=^^Cr 
Rav; Counts in 99mm . -i 95m, Tc window- 1 
51 51 R 4 ? Calculation 1. Corrected Cr cpm= Cr minus x K) 
Q O 
Similarly, the Tc-PYP counts per minute is equal to the 
q Q]ji 
raw counts in the Tc-PYP window minus the counts due to 
in 51 
scatter from higher energy K and Cr. Thus, corrected 
Q Qfj] 
Tc-PYP cpm equals the following equation: 
Q Qrn Q Qm 
Calculation 2. Corrected Tc cpm= Tc minus 
C 1|^ f 51 
x K plus g x Corrected Cr cpm) 
Sample activity was expressed as an activity ratio between 
that of the sample and the mean value of the 6-8 normal sam¬ 
ples obtained in each animal. 
Four sham infarcted animals served as controls for 
these studies. In these animals following intravenous admin¬ 
istration of the soluble radioactive tracers and left-atrial 
microsphere injection, the heart was removed and samples 
obtained and analyzed as outlined previously. 
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RESULTS 
In all 12 animals studied, significant abnormal¬ 
ities existed in the myocardial uptake of and ^^mTc-PYP 
in the infarct zone. Infarct to normal radioactivity ratios 
averaged 0.53 + 0.03 for K and 11.1 + 2.0 for ^ Tc-PYP. 
In each experiment values for infarct zone radioactivity 
were significantly different (p <0.001) from those in normal 
51 
zones. Similarly, Cr microsphere distributions were sig¬ 
nificantly abnormal in the infarct zone (p <0.0 01) with an 
average infarct to normal radioactivity ratio of 0.55 + 0.03* 
The data from a typical experiment are shown in Figure 1. 
In sham Infarct control animals the standard deviation of 
the mean and standard error for samples averaged 6% and 
3% respectively, for ^mTc-PYP 4% and 2% respectively, and 
51 for Cr microspheres 6% and 3% respectively. 
99m 4 3 
When the relationships between Tc-PYP and K 
uptake were compared in 91 samples, no simple linear relation- 
99m 
ship existed. Tc-PYP uptake was maximal in regions asso- 
43 
ciated with K uptake of approximately 0.4 of normal. A 
4 3 positive relationship existed in samples In which K uptake 
, if -3 
was less than 0.4 of normal, such that as K uptake increased, 
Q QjTl 
Tc-PYP uptake similarly increased (r = 0.73). In infarct 
regions with uptake greater than 0.4 of normal, a nega¬ 
tive linear relationship existed, such that as uptake 
99m 
increased and approached normal, Tc-PYP uptake fell 
(r = 0.75) (Figure 2). Similar trends were apparent in com- 
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paring epicardial and endocardial samples as well. 
Microsphere studies based upon the same samples 
from 12 animals demonstrated an excellent linear correlation 
between regional myocardial uptake of the flow related par¬ 
ticles and ionic (Figures 3j4,5). This relationship 
existed for transmural samples (r = 0.93) as well as endo¬ 
cardial (r = 0.97) and epicardial (r = 0.86) portions. In 
extremely low flow regions, the radioactive cation uptake 
was generally greater than that of microspheres. 
On the other hand, the relationship between flow- 
9 
related microsphere distribution and that of Tc-PYP was 
Q 0^ 
by no means linear. Tc-PYP uptake was maximal at relative 
microsphere flow distributions between 0.30 and 0.40 of nor¬ 
mal (Figure 6). At regional myocardial blood flow less than 
Q Qjji 
0.40 of normal, Tc-PYP myocardial uptake increased as flow 
increased; at regional myocardial blood flow rates greater 
than 0.4 of normal, ^mTc-PYP uptake decreased as flow 
approached normal. However, in relatively high flow border 
segments (greater than 0.80 of normal) significant ^mTc-PYP 
uptake of approximately 5-6 times normal persisted. Similar 
trends were noted in comparison of endocardial and epicardial 
samples. 
Of note as well was the transmural distribution of 
99mTc_pYp uptake within the infarct zone (Figure 7). In low 
flow regions, pyrophosphate myocardial uptake was primarily 
epicardial, with endo/epicardial ratios of 0.4-0.5. As the 
regional flow profile increased toward normal, transmural 
27 - 

distribution became equivalent between endocardium and epi- 
cardium. In the highest flow border zones of the infarct, 
Q Qyfi 
Tc-PYP uptake was primarily endocardial with endo-epicar- 
dial ratios of 3-3*5. 
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DISCUSSION 
Radionuclide imaging techniques represent sensitive 
new tools in the clinical armamentarium because they are able 
to describe in a noninvasive manner physiologic and pathologic 
phenomenon not'easily obtainable by other methods. If they 
are to be useful, not only to detect myocardial ischemia 
and infarction, but also to quantify their respective size, 
however, then the factors which govern their individual myo¬ 
cardial uptake must be clearly understood. Such insights 
can be gained from animal models as long as one recognizes 
that direct comparison to man is difficult because species 
variation in coronary anatomy and collateral pathways may be 
significant. 
Initially this study had two objectives: 1) to 
examine the relationship between regional myocardial blood 
flow and the myocardial uptake of the radioactive tracers 
and 99mTc-PYP. 2) To examine the interrelationships 
li o Q^rn 
between myocardial uptake of JK and that of '' Tc-PYP. 
These goals were realized. In addition, other interesting 
99m 
observations about the accumulation of Tc-PYP became 
apparent. 
First of all, there was an excellent correlation 
4 q 
between myocardial uptake of K and regional myocardial 
blood flow as estimated by the radioactive microsphere tech¬ 
nique. This high correlation existed in both endocardial 
and epicardial samples as well as across the entire wall 
thickness. These studies in a closed-chest 24 hour infarct 
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preparation agree closely with data obtained in more acute 
open chest canine preparations by Prokop et al. (32) , Becker 
et al. (47), and Strauss et al. (48). In this study, as 
in the others mentioned, radioactive cation uptake was some¬ 
what greater than that of microspheres in very low flow 
regions. 
99m 
In comparison, the relationship of Tc-PYP to 
regional myocardial blood flow is much more complex. As 
regional myocardial blood flow increases from the central 
0 Qj'q 
infarct zone to the periphery, Tc-PYP accumulation at 
first increases linearly with blood flow; it then reaches 
a maximum at a blood flow reduction of approximately 0.4 
of normal; finally, it decreases linearly as blood flow con¬ 
tinues to increase and approach normal. Although no histo¬ 
logic sections were taken to examine the extent of myocardial 
9 9m 
necrosis, it appears that Tc-PYP uptake in the infarct 
is governed by at least two factors: 1) regional flow to 
the involved area which allows delivery of the radioactive 
tracer, 2) extraction of the tracer which is dependent upon 
myocardial necrosis or ischemic injury. 
Q Orn 
The transmural distribution of Tc-PYP within 
the infarct zone also illustrates the role of regional blood 
flow in determining radionuclide uptake. In regions of 
99m 
lowest flow within the center of the infarct, Tc-PYP uptake 
is predominantly epicardial, with endo-eipcardial ratios of 
0.4-0.5. This occurs despite the fact that the more intense 
local region of necrosis would involve the endocardial sur- 
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face of the infarcted segment. On the other hand, in higher 
flow regions, uptake becomes primarily endocardial. These 
observations of pyrophosphate uptake stand in direct contrast 
to those recently obtained with radioactively labelled myosin 
specific antibodies (23,24). With this radioactive tracer, 
uptake in the central infarction zone is primarily endocar¬ 
dial, and maximal uptake occurs in the lowest flow regions. 
9 9m Thus, it again becomes apparent that Tc-PYP myocardial 
uptake is dependent both on flow and on some alteration of 
the myocardial cell. 
Furthermore, in analysis of the microsphere data 
9 9m 
one notes significant myocardial " Tc-PYP uptake (approxi¬ 
mately 5-3 times normal) in regions where flow is minimally 
if at all reduced (greater than 0.80 of normal). This 
implies either uptake in ischemic but not irreversibly damaged 
cells or uptake by a small population of infarcted myocardial 
cells interspersed with a normal population within the border 
zone. Discrimination between these alternative possibilities 
will require the use of techniques such as autoradiography. 
A possible clinical correlate of this phenomenon might be 
the finding of positive myocardial images of abnormal pyro¬ 
phosphate uptake in patients with unstable angina who demon¬ 
strate neither serum enzyme nor electrocardiographic evidence 
of infarction (17). 
Given the excellent correlation between regional 
43 
myocardial blood flow distribution and K accumulation, one 
would expect the bimodal relationship that is obtained between 
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43 9 9m 51 
K and Tc-PYP to be very simila'r to that between Cr 
9 9m 
and Tc-PYP. This data concerning the relationships 
between pyrophosphate uptake and other radioactive cationic 
myocardial distributions are in general agreement with other 
recent preliminary reports utilizing either radioactive potas¬ 
sium (83), Cesium (77), and Thallium (82). Furthermore, the 
correlative data with both K and microspheres indicate 
that if flow is significantly reduced, then a falloff in max¬ 
imal pyrophosphate uptake would be expected. An in vivo 
imaging concomitant of these observations would be the "dough¬ 
nut" appearance of reduced central ^mTc-PYP accumulation 
noted in images of canine and human infarction involving 
the anterior wall of the left ventricle (8l). 
99m 
Although the biochemical mechanisms governing Tc-PYP 
uptake have not yet been resolved, some extrapolations can be 
made from these data, obtained at the tissue level, to the 
external detection of myocardial radionuclide distributions 
in the patient with myocardial infarction. By using computer 
generated isocount contour maps, one would expect radioactive 
cation distributions to correspond well with flow-related 
parameters of infarcted and ischemic myocardium. On the 
99m 
other hand Tc-PYP uptake might well be lower in central 
infarction zones and excessively high in the perimeter or 
margin zone, such that overall infarct size might be over¬ 
estimated. If "cold and hot spot" tracers were used together, 
subtraction of the isocount distribution of one radionuclide 
from that of the other might allow definition of a region of 
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"missmatch" or "nonalignment." This zone would correspond 
to an ischemic periinfarction area. In addition, sequential 
hot spot imaging following an interim increase in regional 
99m 
myocardial blood flow could lead to increased Tc-PYP 
uptake and apparent worsening on scan although the situation 
in fact, would be Improving. Recent reports emphasize the 
additional information gained by dual radionuclide imaging 
(15,25,26,27,82,83). 
In summary, in the twenty-four hour old canine 
infarct model, dual radionuclide myocardial distribution 
studies reveal a direct correlation between radioactive 
43 
monovalent cation uptake, as measured by K, and regional 
myocardial blood flow. On the other hand, infarct pyrophos¬ 
phate uptake is partially dependent on delivery of the radio¬ 
active tracer to the Infarct zone yielding maximal uptake at 
0.3-0.4 normal flow, with epicardial uptake predominating in 
low flow zones. These data help to define the pathophysiologic 
correlates of dual radionuclide tracer uptake in the myocardium. 
Vincent C. DiCola 

SUMMARY 
The dual radionuclide myocardial distributions of the 
imaging agents potassium-43 ( JK) and technetium-99m stannous 
pyrophosphate (^^mTc-PYP) were studied 24 hours following 
closed-chest canine infarction. In multiple myocardial biop¬ 
sies from 12 dogs, tissue levels of both radionuclides were 
compared and related to estimates of regional myocardial blood 
flow (RMBF) as measured by the distribution of radioactive 
microspheres. 
There was an excellent correlation between myocardial 
43 
K uptake in ischemic and infarcted zones and microsphere 
99m 
estimates of RMBF. The relationship of Tc-PYP uptake to 
microsphere estimates of RMBF was more complex, however, and 
99m 
demonstrated maximal Tc-PYP uptake at flows of 0.3 to 0.4 
9 9m 
of normal. At lower flows Tc-PYP uptake increased with 
9 9m increasing tissue perfusion. At higher flows Tc-PYP uptake 
decreased with increasing tissue perfusion. A similar relation¬ 
ship was noted between the distributions of ^mTc-PYP and ^K. 
Q 
In the low flow regions Tc-PYP uptake was primarily epi- 
cardial; in the higher flow periphery of the infarct endocardial 
9 9m 
uptake predominated and significant endocardial Tc-PYP 
uptake occurred despite near normal RMBF. 
^3 K 
Thus, while there is a direct correlation between cationic 
myocardial uptake and RMBF, no such direct relationship 
- 34 - 

SUMMARY (Continued) 
99m 
exists for Tc-PYP since uptake of this tracer is dependent 
both on the magnitude of necrosis and on flow-related delivery 
of the tracer to the infarct zone. The implications of this 
study for dual radionuclide imaging of infarction are discussed. 
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SAMPLE/ NORMAL 
0.98 
43 
5'C. 
K 
MS 
6.32 7.! 7 8.08 10.3 12.5 6.81 1 1.73 3.06 
0. 1 3 0.12 0. 18 0.26 0.48 0 80 0. 38 0.94 
0. 12 0. !9 0. 20 0.30 044 0.77 0.39 094 
FIGURE 1. DIagramatic representation of the topography of 
dual radionuclide distribution in. an Individual 
study. The stippled area Indicates the visually 
appreciated zone of infarction. The plug embolus 
is situated In the left anterior descending cor¬ 
onary artery just proximal to the last large diag¬ 
onal branch. The numbers in circles correspond 
to sample biopsy sites in the individual experiment. 
Sample activities for technetium-99m pyrophosphate, 
potassium-43 and chromium-51 microspheres are 
expressed as activity ratios between the infarct 
sample and the mean of 6-8 normal biopsies remote 
from the infarct. Abnormality in potassium-43 
uptake parallels chromium-51 microsphere distrib¬ 
ution. Highest technetium-99m pyrophosphate act¬ 
ivity is noted in sample 6 which is near the margin 
of infarction and has only moderate reduction in 
potassium-43 and chromium-51 microsphere uptake. 
Relatively low technetium-99m pyrophsophate activity 
is noted in sample 4 which has the lowest potass¬ 
ium-43 and chromium-51 microsphere accumulation. 

35 
30 
43K< 0 
y « 32.75x + 3 89 
r = 0 73 
n * 35 
p <0 001 
43K>0.40 
y * -25.5lx+ 28.79 
r = -0.75 
n = 56 
p < 0 001 
25 
20 
15 
10 
5 - 
• #* 
• • 
* '• •• 
• \ 
010 0.20 0.30 040 0.50 0.60 0.70 0.80 0.90 1.00 1.10 1.20 
43k infarct / normal 
FIGURE 2. Relationship between myocardial potassium-43 and 
technetium-99m pyrophosphate activities in 91 
samples from 12 dogs. Note that maximum technet- 
ium-99m pyrophosphate activity occurs at potass¬ 
ium-43 levels between 0.30 and 0.40 of normal. 
Two significant linear relationships are evident. 
At potassium-43 levels below 0.4 of normal, tech- 
netium-99m pyrophosphate levels increase as potas¬ 
sium-43 activity increases. At potassium-43 levels 
greater than 0.40 of normal, technetium-99m pyro¬ 
phosphate decreases as potassium-43 increases toward 
normal. 
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RELATIONSHIP OF TRANSMURAL 43K 
AND 51 Cr MICROSPHERES 
FIGURE 3. Significant linear relationship is evident betwee 
potassium-43 uptake and chromium-51 microsphere 
distributions in transmural samples. 
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FIGURE 
51 
RELATIONSHIP OF 43K AND 
Cr MICROSPHERE ENDOCARDIAL DISTRIBUTIONS 
1.00 
0.90 
0.80 
0.70 
y = 0.91 x + 0 09 
r = 0 97 
n = 91 
p <0.001 
• • 
0.60 
0.50 
0.40 
% 0.30 
I_I 
0.40 0.60 
MICROSPHERES 
I_I 
0.80 1.00 
INFARCT / NORMAL 
l 
1.20 
Significant linear relationship is evident between 
potassium-43 uptake and chromium-51 microsphere 
distributions in endocardial samples. 
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FIGURE 
RELATIONSHIP OF 43K AND 
51Cr MICROSPHERE EPICARDIAL DISTRIBUTIONS 
1.00 
0.90 
0.80 
0.70 
0.60 
0.50 
0.40 
y = 0.71 x + 0.18 • • 
r = 0.86 
n = 91 
p < 0.001 
0.30 - 
0.20 - 
0.10 i- 
r 
0.00 — 
.00 0.20 0.40 0.60 
5,Cr MICROSPHERES 
I_l 
0.80 1.00 
INFARCT / NORMAL 
I 
1.20 
8 
1.40 
5. Significant linear relationship is evident between 
potassium-43 uptake and chromium-51 microsphere 
distributions in epicardial samples. 
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5lCr MICROSPHERES INFARCT / NORM AL 
FIGURE 6. Relationships between myocardial technetium-99m 
pyrophosphate and chromium-5i microsphere dis¬ 
tributions in the transmural sample. Note the 
similarity in distributions to the relationships 
between potassium-43 and technetium-99m pyro¬ 
phosphate; uptake is again maximal at relative 
flows of between 0.30 - 0.40 of normal. Note 
the frequent finding of abnormal technetium-99m 
pyrophosphate uptake in relatively high flow 
border zones. 
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TRANSMURAL 51Cr MICROSPHERES INFARCT / NORMAL 
FIGURE 7. Endocardial and epicardial distributions of tech- 
netium-99m pyrophosphate in relation to chromium-51 
microsphere estimates of relative blood flow in 91 
samples from 12 dogs. Epicardial activity is shown 
by the cross-hatched bars, endocardial activity by 
the open bars. SEM is given for each group. P 
values refer to significant differences between 
endo- and epicardial portions within each flow zone. 
Note that technetium-99m pyrophosphate uptake is 
primarily epicardial in low flow zones, with a grad¬ 
ual transition as flow increases toward normal. 
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